Paclitaxel (Sagent Pharmaceuticals)


Welcome to the PulseAid listing for the Paclitaxel drug offered from Sagent Pharmaceuticals. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sagent Pharmaceuticals
NON-PROPRIETARY NAME: paclitaxel
SUBSTANCE NAME: PACLITAXEL
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Microtubule Inhibition [PE],Microtubule Inhibitor [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2011-09-27
END MARKETING DATE: 0000-00-00


Paclitaxel HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPaclitaxel from Sagent Pharmaceuticals
LABELER NAME: Sagent Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 6(mg/mL)
START MARKETING DATE: 2011-09-27
END MARKETING DATE: 0000-00-00
PRODUCT ID: 25021-213_3473cc55-601b-4925-8cf5-06f1835f9ede
PRODUCT NDC: 25021-213
APPLICATION NUMBER: ANDA090130

Other PACLITAXEL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Abraxis BioScience, LLCABRAXANE
Actavis Pharma, Inc.Paclitaxel
Athenex Pharmaceutical Division, LLC.Paclitaxel
Breckenridge Pharmaceutical, Inc.Paclitaxel
Fresenius Kabi USA, LLCPaclitaxel
Gland Pharma LimitedPACLITAXEL
Hospira, Inc.Paclitaxel
Mylan Institutional LLCPaclitaxel
Pfizer Laboratories Div Pfizer Inc.paclitaxel
Sagent PharmaceuticalsPaclitaxel
Sandoz IncPaclitaxel
Teva Parenteral Medicines, Inc.Paclitaxel
WG Critical Care, LLCPaclitaxel